Edition:
India

Wacker Chemie AG (WCHG.DE)

WCHG.DE on Xetra

65.08EUR
9:05pm IST
Change (% chg)

€-0.32 (-0.49%)
Prev Close
€65.40
Open
€65.40
Day's High
€65.94
Day's Low
€64.38
Volume
176,531
Avg. Vol
173,600
52-wk High
€98.74
52-wk Low
€57.86

Latest Key Developments (Source: Significant Developments)

Wacker Chemie Q2 Net Income Down 55.4% To EUR 37 Million
Thursday, 1 Aug 2019 

Aug 1 (Reuters) - Wacker Chemie AG ::Q2 NET PROFIT 37 MILLION EUR.Q2 EBIT 70.7 MILLION EUR VERSUS 125 MILLION EUR YEAR AGO.NET INCOME FOR Q2 2019 AMOUNTS TO EUR37 MILLION.FULL-YEAR FORECAST UNCHANGED.GROUP SALES FOR Q2 2019 COME IN AT EUR1.27 BILLION, DOWN 5 PERCENT YEAR OVER YEAR, BUT UP 3 PERCENT QUARTER OVER QUARTER.Q2 EBITDA (EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION AND AMORTIZATION) OF EUR210.7 MILLION.  Full Article

Wacker Chemie Confirms 2019 Sales And Earnings Forecast
Thursday, 23 May 2019 

May 23 (Reuters) - Wacker Chemie AG ::DGAP-NEWS: WACKER CHEMIE AG: ANNUAL SHAREHOLDERS' MEETING 2019: WACKER EXPECTS TO POST CONTINUED GROWTH IN CURRENT FISCAL YEAR.2019 SALES AND EARNINGS FORECAST AFFIRMED.  Full Article

Wacker Chemie Says EBITDA Down 44 Pct In Q1
Thursday, 25 Apr 2019 

April 25 (Reuters) - Wacker Chemie AG ::DGAP-NEWS: WACKER CHEMIE AG: WACKER LIFTS ITS SALES IN Q1 2019 AND CONFIRMS FULL-YEAR FORECAST.GROUP SALES FOR Q1 2019 REACH EUR1.24 BILLION, UP 2 PERCENT YEAR OVER YEAR AND 4 PERCENT QUARTER OVER QUARTER.AT EUR142 MILLION, EBITDA DECLINES 44 PERCENT VERSUS A YEAR AGO AND 18 PERCENT QUARTER OVER QUARTER, SLOWED BY LOWER POLYSILICON PRICES, HIGHER ENERGY COSTS AND A TEMPORARY OUTAGE AT A SILICONE-RUBBER PLANT.NET RESULT FOR Q1 2019 AMOUNTS TO EUR-6 MILLION.AT EUR-135 MILLION, NET CASH FLOW IS CLEARLY NEGATIVE, DUE PARTLY TO HIGHER CAPITAL EXPENDITURES AND INCREASED WORKING CAPITAL.FULL-YEAR FORECAST CONFIRMED: GROUP SALES FOR 2019 EXPECTED TO GROW BY A MID-SINGLE-DIGIT PERCENTAGE, WITH EBITDA LIKELY TO DECLINE BY 10 TO 20 PERCENT VERSUS LAST YEAR.  Full Article

Wacker Chemie Issues Guidance For 2019
Tuesday, 5 Mar 2019 

March 5 (Reuters) - WACKER CHEMIE AG ::ISSUES GUIDANCE FOR 2019.EXPECTS GROUP SALES TO CLIMB BY A MID-SINGLE-DIGIT PERCENTAGE VERSUS LAST YEAR'S EUR4.98 BILLION.2019 EBITDA WILL BE BETWEEN 10 AND 20 PERCENT LOWER THAN LAST YEAR'S FIGURE (EUR930 MILLION).EXPECTS NET CASH FLOW FOR 2019 TO BE CLEARLY POSITIVE AND SIGNIFICANTLY HIGHER THAN LAST YEAR'S FIGURE (EUR125 MILLION).SIGNIFICANT CONTRIBUTING FACTOR TO PROJECTED EBITDA DECLINE ARE LOWER AVERAGE PRICES ANTICIPATED FOR POLYSILICON THIS YEAR.  Full Article

Wacker Chemie: Wacker Polymers To Raise Prices For Dispersions And Dispersible Polymer Powders
Tuesday, 12 Jun 2018 

June 12 (Reuters) - Wacker Chemie AG ::WACKER POLYMERS TO RAISE PRICES FOR DISPERSIONS AND DISPERSIBLE POLYMER POWDERS.EFFECTIVE JULY 1, 2018, PRICES WILL BE RAISED BY UP TO TEN PERCENT.  Full Article

Wacker Chemie: Contract Of Executive Board Member Auguste Willems Extended Until 2023
Tuesday, 6 Mar 2018 

March 6 (Reuters) - Wacker Chemie AG ::DGAP-NEWS: WACKER CHEMIE AG: SUPERVISORY BOARD EXTENDS THE CONTRACT OF EXECUTIVE BOARD MEMBER AUGUSTE WILLEMS UNTIL 2023.  Full Article

Wacker Chemie AG ‍Full-Year 2017 Group Sales Climb 6 Percent
Thursday, 8 Feb 2018 

Feb 8 (Reuters) - Wacker Chemie Ag ::‍FULL-YEAR 2017 GROUP SALES CLIMB 6 PERCENT TO EUR4.92 BILLION​.‍EBITDA OF EUR1.015 BILLION COMES IN 6 PERCENT HIGHER YEAR OVER YEAR​.‍SALES FOR Q4 2017 GROW TO EUR1.18 BILLION, 3 PERCENT MORE VERSUS A YEAR EARLIER​.‍FINAL-QUARTER EBITDA CLIMBS 6 PERCENT TO EUR235 MILLION​.‍EBIT INCREASES 24 PERCENT TO EUR420 MILLION IN 2017​.‍INCOME FROM CONTINUING OPERATIONS CLIMBS 40 PERCENT TO EUR250 MILLION, WITH NET INCOME FOR YEAR TOTALING EUR885 MILLION​.‍GROUP SALES FROM OCTOBER THROUGH DECEMBER 2017 TOTALED AROUND EUR1.18 BILLION (Q4 2016: EUR1.15 BILLION)​.‍Q4 EBITDA REACHED EUR235 MILLION IN Q4 2017 (Q4 2016: EUR221 MILLION), A RISE OF 6 PERCENT​.  Full Article

Wacker Chemie Wins FDA OK To Make Drug Substance In Chiesi's Retavase
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Wacker Chemie AG ::SAYS OBTAINS FDA APPROVAL TO MANUFACTURE THE DRUG SUBSTANCE IN RETAVASE, A THROMBOLYSIS MEDICATION BY CHIESI‍​.  Full Article

Wacker Chemie Supervisory Board Extends Contract Of CEO Rudolf Staudigl
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - WACKER CHEMIE AG ::DGAP-NEWS: WACKER CHEMIE AG: SUPERVISORY BOARD EXTENDS THE CONTRACTS OF CEO RUDOLF STAUDIGL AND EXECUTIVE BOARD MEMBER CHRISTIAN HARTEL.RUDOLF STAUDIGL RE-APPOINTED AS PRESIDENT & CEO UNTIL 2021.  Full Article

Siltronic ups outlook for sales, EBITDA margin
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Siltronic Ag :Says ‍production of 300 mm and 200 mm wafers has already been fully loaded for five consecutive quarters​.Says ‍q3 sales up 9 percent on previous quarter​.Says ‍q3 ebitda up 46 percent on previous quarter​.Says ‍q3 ebitda margin of 35 percent​.Says ‍forecast raised slightly​.Says ‍slightly raises 2017 forecast and now expects sales of at least eur 1.16 billion and an ebitda margin of at least 29 percent​.  Full Article

German stocks - Factors to watch on May 23

BERLIN/FRANKFURT, May 23 The following are some of the factors that may move German stocks on Thursday: